Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (14,286,756)	$ (112,662,027)	$ (37,127,303)
Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development		72,523,293
Depreciation and amortization	7,052	4,403	12,829
Stockbased compensation	444,459	16,981,266	7,813,743
Amortization of right of use lease asset		182,042	258,848
Foreign currency loss (gain)	38,926	(281,534)	(317,402)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	451,994	2,190,086	(109,338)
Accounts payable	827,463	(858,513)	(2,730,587)
Accrued expenses	(189,720)	(2,903,450)	(5,218,241)
Deferred grant revenue	528,974
Lease liability		(186,702)	(268,728)
Net cash used in operating activities	(12,177,608)	(25,011,136)	(37,686,179)
Cash flows from investing activities:
Purchases of property and equipment	(93,093)
Net cash used in investing activities	(93,093)
Cash flows from financing activities:
Proceeds from the exercise of stock options			208,367
Proceeds from issuance of common stock	5,788,918	682,973	1,538,645
Common stock issuance costs	(648,928)
Net cash provided by financing activities	5,139,990	682,973	1,747,012
Change in cash and cash equivalents and restricted cash	(7,130,711)	(24,328,163)	(35,939,167)
Effect of exchange rate changes on cash	(8,399)	38,758	(2,467)
Cash, cash equivalents and restricted cash-beginning of year	28,786,647	53,076,052	89,017,686
Cash, cash equivalents and restricted cash-end of year	21,647,537	28,786,647	53,076,052
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents	21,606,820	28,786,647	53,076,052
Restricted cash	40,717
Total cash, cash equivalents and restricted cash	$ 21,647,537	28,786,647	53,076,052
Non-cash investing and financing activities:
Operating lease liabilities arising from obtaining right-of-use assets		123,786	$ 124,043
Issuance of convertible preferred stock and common stock in connection with acquisition		$ 70,107,167